1
Total investments
0
Early stage
0
Mid stage
0
Late stage
2y
Years active
Portfolio
0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 2 entries
All (2)
Investments (1)
2024
Commercial Partnerships Lead
Nov 2024
Around 27% of essential drugs on the FDA list are categorised as at risk due to uncertain supply chains. CyanoCapture is an advanced Synthetic Biology company that is leveraging the worlds fastest carbon-negative cell to synthesise drug precursor molecules at lower cost and address this problem.
Winner - Elon Musk XPRIZE 2021
Winner - Shell New Energy Challenge 2022
Winner - Horizon Europe 2024
Winner - LOreal GSI x Hello Tomorrow 2024
Enquiries:
Partnerships@cyanocapture.com
Licensing@cyanocapture.com
Visiting Investor
May 2024
The Oxford Seed Fund is a founder-friendly team comprising students and alumni from the University of Oxford. We invest up to £100,000 in early-stage startups where the founding team has at least one current student, alumni or academic staff member from the university, and provide additional support to scale.
Supported by the Oxford Saïd Entrepreneurship Centre at Saïd Business School, University of Oxford.